Prolonged febrile illness following first dose of ChAdOx1

A woman in her 40s, with a known history of fibromyalgia, presented with high-grade fever and constitutional symptoms occurring 5 days following vaccination with Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1). Her inflammatory markers and neutrophil count were found to be elevated and as such, she wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruana Dingli, Michael, Bugeja, Luke, Camilleri, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Reports: Adverse drug reactions and complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401244/
https://www.ncbi.nlm.nih.gov/pubmed/37536942
http://dx.doi.org/10.1136/bcr-2022-253671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401244/
https://www.ncbi.nlm.nih.gov/pubmed/37536942
http://dx.doi.org/10.1136/bcr-2022-253671

Ejemplares similares